InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Monte Rosa Therapeutics, Inc.

GLUE Clue Score47
United States Fiscal year ends December CIK 0001826457 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

18
Insider
Date
Role
Action
Shares
Price
Amount
Jennifer Champoux
15 Jul 2026
Chief Operating Officer
Sold after exercise
4,351
$23.38
$101.73K
Sharon Townson
6 Jul 2026
Chief Scientific Officer
Sold after exercise
400
$24.13
$9.65K
Sharon Townson
6 Jul 2026
Chief Scientific Officer
Sold after exercise
5,600
$23.25
$130.20K
Filip Janku
30 Jun 2026
Chief Medical Officer
Sold after exercise
5,407
$24.50
$132.47K
Anthony M. Manning
29 Jun 2026
Director
Sold after exercise
10,000
$23.11
$231.10K
Filip Janku
29 Jun 2026
Chief Medical Officer
Sold after exercise
6,000
$22.95
$137.70K
Filip Janku
24 Jun 2026
Chief Medical Officer
Sold after exercise
30,000
$21.42
$642.68K
Sharon Townson
23 Jun 2026
Chief Scientific Officer
Sold after exercise
3,000
$20.00
$60.00K
Jennifer Champoux
23 Jun 2026
Chief Operating Officer
Sold after exercise
2,175
$20.00
$43.50K
Filip Janku
23 Jun 2026
Chief Medical Officer
Sold after exercise
11,845
$20.22
$239.52K
Sharon Townson
17 Jun 2026
Chief Scientific Officer
Sold after exercise
3,000
$19.00
$57.00K
Jennifer Champoux
17 Jun 2026
Chief Operating Officer
Sold after exercise
2,176
$19.00
$41.34K
Sharon Townson
29 May 2026
Chief Scientific Officer
Sold after exercise
6,000
$19.87
$119.22K
Jennifer Champoux
27 May 2026
Chief Operating Officer
Sold after exercise
2,175
$20.00
$43.50K
Jennifer Champoux
22 May 2026
Chief Operating Officer
Sold after exercise
2,176
$19.00
$41.34K
Anthony M. Manning
21 May 2026
Director
Sold after exercise
10,000
$18.01
$180.10K
Edmund Dunn
2 Mar 2026
Principal Accounting Officer
Sold after exercise
536
$17.50
$9.38K
Edmund Dunn
27 Feb 2026
Principal Accounting Officer
Sold after exercise
25,164
$18.10
$455.51K
Show all 64 transactions →

What was left out

Form 4 filings counted 135
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 18
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 109,003,555
History held since 25 Jun 2021